Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
EcoR1 Capital
company
About
EcoR1 Capital is a biotech-focused investment advisory firm.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Financial Services
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- PE,Venture Capital
Investments
Number of Investments
Number of Lead Investments
13
3
EcoR1 Capital has made 13 investments. Their most recent investment was on
Jan 6, 2022, when Eikon Therapeutics raised $518M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
|
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | Yes |
|
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | Yes |
|
Sep 14, 2020
Neogene Therapeutics
|
Series A | $110M | Biotechnology | Yes |
|
Aug 26, 2020
Freenome
|
Series C | $270M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
